Schedule 13G ownership disclosure

FIVE PRIME THERAPEUTICS INC

Security class unavailable · CUSIP: 33830X104

Event date: 2019-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-19-002489
Form type
SC 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Oct 02, 2019
Reporting period
Sep 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub